<?xml version="1.0" encoding="utf-8" ?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom"><channel><title>NOVOGEN 9 RSS Feed | Nachrichten - www.finanzen.net</title><description>www.finanzen.net bietet Finanznachrichten zum weltweiten Börsengeschehen</description><category>Finanzen</category><link>https://www.finanzen.net</link><language>de-de</language><copyright>finanzen.net GmbH</copyright><lastBuildDate>Fri, 19 Jun 2026 17:27:46 +0200</lastBuildDate><atom:link href="https://www.finanzen.net/rss/novogen%5F9%2Drss%2Dfeed" rel="self" type="application/rss+xml"/><image><url>https://images.finanzen.net/images/finanzen_net_neu.gif</url><title>NOVOGEN 9 RSS Feed | Nachrichten - www.finanzen.net</title><link>https://www.finanzen.net</link></image><item><title>Kazia Therapeutics to Participate in J.P. Morgan Healthcare Conference Week; Clinical and Translational Update Anticipated Before Month-End</title><pubDate>Thu, 08 Jan 2026 15:00:00 +0100</pubDate><link>https://www.finanzen.net/nachricht/aktien/kazia-therapeutics-to-participate-in-j-p-morgan-healthcare-conference-week-clinical-and-translational-update-anticipated-before-month-end-15402245</link><description><![CDATA[<p><p xmlns="http://www.w3.org/1999/xhtml"><span class="legendSpanClass"><span class="xn-location">SYDNEY, <span class="legendSpanClass"><span class="xn-chron">Jan. 8, 2026 /PRNewswire/ -- Kazia Therapeutics (NASDAQ: KZIA) today announced that its Chief  ...</p>]]></description><guid isPermaLink="true">https://www.finanzen.net/nachricht/aktien/kazia-therapeutics-to-participate-in-j-p-morgan-healthcare-conference-week-clinical-and-translational-update-anticipated-before-month-end-15402245</guid></item><item><title>Kazia Therapeutics Regains Full Nasdaq Listing Compliance</title><pubDate>Mon, 22 Dec 2025 14:00:00 +0100</pubDate><link>https://www.finanzen.net/nachricht/aktien/kazia-therapeutics-regains-full-nasdaq-listing-compliance-15374425</link><description><![CDATA[<p><p xmlns="http://www.w3.org/1999/xhtml"><i>Restoration of Nasdaq compliance follows <span class="xn-money">$50 million institutional financing and reinforces balance-sheet strength</i><p xmlns="http://www.w3.org/1999/xhtml"><span class="legendSpanClass"><span  ...</p>]]></description><guid isPermaLink="true">https://www.finanzen.net/nachricht/aktien/kazia-therapeutics-regains-full-nasdaq-listing-compliance-15374425</guid></item></channel></rss>
